Literature DB >> 20511668

Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma.

Silvia Zibellini1, Daniela Capello, Francesco Forconi, Paolo Marcatili, Davide Rossi, Sara Rattotti, Silvia Franceschetti, Elisa Sozzi, Emanuele Cencini, Roberto Marasca, Luca Baldini, Alessandra Tucci, Francesco Bertoni, Francesco Passamonti, Ester Orlandi, Marzia Varettoni, Michele Merli, Silvia Rizzi, Valter Gattei, Anna Tramontano, Marco Paulli, Gianluca Gaidano, Luca Arcaini.   

Abstract

Antigen stimulation may be important for splenic marginal zone lymphoma pathogenesis. To address this hypothesis, the occurrence of stereotyped B-cell receptors was investigated in 133 SMZL (26 HCV+) compared with 4,414 HCDR3 sequences from public databases. Sixteen SMZL (12%) showed stereotyped BCR; 7 of 86 (8%) SMZL sequences retrieved from public databases also belonged to stereotyped HCDR3 subsets. Three categories of subsets were identified: i) "SMZL-specific subsets" (n=5), composed only of 12 SMZL (9 HCV-from our series); ii) "Non-Hodgkin's lymphoma-like subsets" (n=5), comprising 5 SMZL (4 from our series) clustering with other indolent lymphomas; iii) "CLL-like subsets" (n=6), comprising 6 SMZL (3 from our series) that belonged to known CLL subsets (n=4) or clustered with public CLL sequences. Immunoglobulin 3D modeling of 3 subsets revealed similarities in antigen binding regions not limited to HCDR3. Overall, data suggest that the pathogenesis of splenic marginal zone lymphoma may involve also HCV-unrelated epitopes or an antigenic trigger common to other indolent lymphomas.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20511668      PMCID: PMC2948108          DOI: 10.3324/haematol.2010.025437

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  23 in total

1.  Comparative protein modelling by satisfaction of spatial restraints.

Authors:  A Sali; T L Blundell
Journal:  J Mol Biol       Date:  1993-12-05       Impact factor: 5.469

2.  A simple method for displaying the hydropathic character of a protein.

Authors:  J Kyte; R F Doolittle
Journal:  J Mol Biol       Date:  1982-05-05       Impact factor: 5.469

3.  Standard conformations for the canonical structures of immunoglobulins.

Authors:  B Al-Lazikani; A M Lesk; C Chothia
Journal:  J Mol Biol       Date:  1997-11-07       Impact factor: 5.469

4.  Tumor cells of hairy cell leukemia express multiple clonally related immunoglobulin isotypes via RNA splicing.

Authors:  F Forconi; S S Sahota; D Raspadori; C I Mockridge; F Lauria; F K Stevenson
Journal:  Blood       Date:  2001-08-15       Impact factor: 22.113

5.  Analysis of the IgV(H) somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course.

Authors:  Patricia Algara; Marisol S Mateo; Margarita Sanchez-Beato; Manuela Mollejo; Immaculada C Navas; Lourdes Romero; Francesc Solé; Marta Salido; Lourdes Florensa; Pedro Martínez; Elias Campo; Miguel A Piris
Journal:  Blood       Date:  2002-02-15       Impact factor: 22.113

6.  V(H) gene analysis of splenic marginal zone lymphomas reveals diversity in mutational status and initiation of somatic mutation in vivo.

Authors:  Delin Zhu; Jennifer Orchard; David G Oscier; Dennis H Wright; Freda K Stevenson
Journal:  Blood       Date:  2002-10-01       Impact factor: 22.113

7.  Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity?

Authors:  David Saadoun; Felipe Suarez; François Lefrere; Françoise Valensi; Xavier Mariette; Achille Aouba; Caroline Besson; Bruno Varet; Xavier Troussard; Patrice Cacoub; Oliver Hermine
Journal:  Blood       Date:  2004-09-07       Impact factor: 22.113

8.  Splenic marginal zone lymphoma with villous lymphocytes shows on-going immunoglobulin gene mutations.

Authors:  Anne Tierens; Jan Delabie; Agnieszka Malecka; Junbai Wang; Alicja Gruszka-Westwood; Daniel Catovsky; Estella Matutes
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

9.  Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome.

Authors:  Davide Rossi; Valeria Spina; Michaela Cerri; Silvia Rasi; Clara Deambrogi; Lorenzo De Paoli; Luca Laurenti; Rossana Maffei; Francesco Forconi; Francesco Bertoni; Emanuele Zucca; Claudio Agostinelli; Antonello Cabras; Marco Lucioni; Maurizio Martini; Michele Magni; Silvia Deaglio; Marco Ladetto; Josep F Nomdedeu; Caroline Besson; Antonio Ramponi; Vincenzo Canzonieri; Marco Paulli; Roberto Marasca; Luigi M Larocca; Antonino Carbone; Stefano A Pileri; Valter Gattei; Gianluca Gaidano
Journal:  Clin Cancer Res       Date:  2009-06-09       Impact factor: 12.531

10.  Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia.

Authors:  Bradley T Messmer; Emilia Albesiano; Dimitar G Efremov; Fabio Ghiotto; Steven L Allen; Jonathan Kolitz; Robin Foa; Rajendra N Damle; Franco Fais; Davorka Messmer; Kanti R Rai; Manlio Ferrarini; Nicholas Chiorazzi
Journal:  J Exp Med       Date:  2004-08-16       Impact factor: 14.307

View more
  34 in total

Review 1.  Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities.

Authors:  Nicholas Chiorazzi; Manlio Ferrarini
Journal:  Blood       Date:  2010-12-09       Impact factor: 22.113

2.  Biological and clinical significance of stereotyped B-cell receptors in chronic lymphocytic leukemia.

Authors:  Davide Rossi; Gianluca Gaidano
Journal:  Haematologica       Date:  2010-12       Impact factor: 9.941

3.  Nuclear factor-κB dysregulation in splenic marginal zone lymphoma: new therapeutic opportunities.

Authors:  Luca Arcaini; Davide Rossi
Journal:  Haematologica       Date:  2012-05       Impact factor: 9.941

4.  Antibody modeling using the prediction of immunoglobulin structure (PIGS) web server [corrected].

Authors:  Paolo Marcatili; Pier Paolo Olimpieri; Anna Chailyan; Anna Tramontano
Journal:  Nat Protoc       Date:  2014-11-06       Impact factor: 13.491

5.  Toll-like receptor stimulation in splenic marginal zone lymphoma can modulate cell signaling, activation and proliferation.

Authors:  Eleonora Fonte; Andreas Agathangelidis; Daniele Reverberi; Stavroula Ntoufa; Lydia Scarfò; Pamela Ranghetti; Giovanna Cutrona; Alessandra Tedeschi; Aliki Xochelli; Federico Caligaris-Cappio; Maurilio Ponzoni; Chrysoula Belessi; Zadie Davis; Miguel A Piris; David Oscier; Paolo Ghia; Kostas Stamatopoulos; Marta Muzio
Journal:  Haematologica       Date:  2015-08-20       Impact factor: 9.941

6.  IgM peak independently predicts treatment-free survival in chronic lymphocytic leukemia and correlates with accumulation of adverse oncogenetic events.

Authors:  D Rizzo; J Chauzeix; F Trimoreau; J B Woillard; F Genevieve; A Bouvier; J Labrousse; C Poli; E Guerin; N Dmytruk; L Remenieras; J Feuillard; N Gachard
Journal:  Leukemia       Date:  2014-06-19       Impact factor: 11.528

7.  Multiple myeloma shows no intra-disease clustering of immunoglobulin heavy chain genes.

Authors:  Simone Ferrero; Daniela Capello; Mirija Svaldi; Michela Boi; Daniela Gatti; Daniela Drandi; Davide Rossi; Sara Barbiero; Barbara Mantoan; Elisabetta Mantella; Manuela Zanni; Paola Ghione; Alessandra Larocca; Roberto Passera; Francesco Bertoni; Valter Gattei; Francesco Forconi; Luca Laurenti; Giovanni Del Poeta; Roberto Marasca; Sergio Cortelazzo; Gianluca Gaidano; Antonio Palumbo; Mario Boccadoro; Marco Ladetto
Journal:  Haematologica       Date:  2011-12-29       Impact factor: 9.941

8.  First-line treatment with bendamustine and rituximab, in patients with intermediate-/high-risk splenic marginal zone lymphomas.

Authors:  Roberto Castelli; Luigi Bergamaschini; Giorgio Lambertenghi Deliliers
Journal:  Med Oncol       Date:  2017-12-29       Impact factor: 3.064

9.  High-throughput sequencing of the B-cell receptor in African Burkitt lymphoma reveals clues to pathogenesis.

Authors:  Katharine A Lombardo; David G Coffey; Alicia J Morales; Christopher S Carlson; Andrea M H Towlerton; Sarah E Gerdts; Francis K Nkrumah; Janet Neequaye; Robert J Biggar; Jackson Orem; Corey Casper; Sam M Mbulaiteye; Kishor G Bhatia; Edus H Warren
Journal:  Blood Adv       Date:  2017-03-21

10.  Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features.

Authors:  Alba Navarro; Guillem Clot; Cristina Royo; Pedro Jares; Anastasia Hadzidimitriou; Andreas Agathangelidis; Vasilis Bikos; Nikos Darzentas; Theodora Papadaki; Itziar Salaverria; Magda Pinyol; Xavier Puig; Jara Palomero; Maria Carmela Vegliante; Virgina Amador; Alejandra Martinez-Trillos; Lenka Stefancikova; Adrian Wiestner; Wyndham Wilson; Christiane Pott; Maria Jose Calasanz; Nicola Trim; Wendy Erber; Birgitta Sander; German Ott; Andreas Rosenwald; Dolors Colomer; Eva Giné; Reiner Siebert; Armando Lopez-Guillermo; Kostas Stamatopoulos; Sílvia Beà; Elías Campo
Journal:  Cancer Res       Date:  2012-08-20       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.